Immunodeficiency News and Research

RSS

Immunodeficiency (or immune deficiency) is a state in which the immune system's ability to fight infectious disease is compromised or entirely absent.

Discovery of new ways to manipulate AIDS virus

Researchers at the National Cancer Institute, have discovered new information about how human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency (AIDS), possibly evades eradication from the body.

16 Aug 2004

Dynamics between disposable and reusable segments affect expansion of disposable drapes and gowns markets

The market for disposable surgical drapes and gowns in Europe has seen steady growth in the recent past owing to the high standards of infection control enforced by the new European Union Medical Device Directive (MDD) and EU regulations.

11 Aug 2004

Approval of an injectable filler to correct facial fat loss in people with HIV/AIDS

The Food and Drug Administration has approved an injectable filler to correct facial fat loss in people with human immunodeficiency virus (HIV) infection.

5 Aug 2004

Risk of pelvic inflammatory disease (PID) decreases with condom use

A multi-center study from the University of Pittsburgh's Graduate School of Public Health suggests that women wishing to decrease their risk of pelvic inflammatory disease (PID) should ensure that their sexual partners use condoms consistently.

31 Jul 2004

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

An international study with nearly 900 patients co-infected with Human Immunodeficiency Virus (HIV) and hepatitis C virus (HCV) has shown that HCV can be treated effectively and safely, without compromising the patient’s HIV therapy.

29 Jul 2004

Yoweri Kaguta Museveni has caused a major divide among participants of the AIDS Conference in Thailand

The president of Uganda, Yoweri Kaguta Museveni has caused a major divide among participants at the 15th International AIDS Conference in Thailand by stating that abstinence and marriage are the best ways to stop the spread of the HIV/AIDS epidemic.

12 Jul 2004

Widespread prenatal HIV screening and use of antiretroviral drugs in pregnant HIV-infected women is needed

Rapid testing during labor can enable pregnant women with undocumented HIV status to learn their HIV infection status so they can receive antiretroviral prophylaxis and be referred for comprehensive medical care and follow-up according to a report in the current issue of the Journal of the American Medical Association.

11 Jul 2004

Comparison of antiretroviral therapies shows that tenofovir DF and stavudine are equally effective

Results from a three year double-blinded trial which compared antiretroviral therapies show that the combination regimens of tenofovir DF and stavudine, are equally effective, though tenofovir DF has more favorable outcomes with respect to cholesterol levels and the nervous system.

11 Jul 2004

Nevirapine effective in reducing the risk of transmission of HIV at birth

A drug called nevirapine has been shown to be effective in reducing the risk of transmission of HIV at birth, but combination therapy of nevirapine and zidovudine does not improve outcomes, according to a study published in the current HIV/AIDS Journal of the American Medical Association.

11 Jul 2004

Launch of the Jeffrey Modell Diagnostic Center for Primary Immunodeficiencies

Mattel Children's Hospital at UCLA announced the launch of the Jeffrey Modell Diagnostic Center for Primary Immunodeficiencies at UCLA June 28.

29 Jun 2004

Ugandans highly knowledgeable about HIV vaccine and willing to participate in future trials

A majority of Ugandan study participants are familiar with the benefits of vaccines and are willing to participate in future HIV-preventive vaccine trails

20 Jun 2004

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

17 Jun 2004

WHO welcomes G8 endorsement of the Global HIV Vaccine Enterprise

The World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) today welcomed the G8's endorsement of the Global HIV Vaccine Enterprise, a virtual consortium proposed by an international group of scientists that is being established to accelerate HIV vaccine development.

11 Jun 2004

Double-punch approach to vaccine design more effective

A study revealing new information about how viral proteins move between cells and alert the immune system suggests that a double-punch approach to vaccine design would make them more effective.

1 Jun 2004

Research into flipping genes therapy by Leeds University

Graham Cook and Erica de Wynter of molecular medicine have secured £125,000 to investigate the unique way antibody genes are assembled and how they can be harnessed to fight disease.

25 May 2004

$3.5 million grant to develop AIDS vaccinations

Researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate Research Center at Oregon Health & Science University have received a $3.5 million grant from the National Institutes of Health to develop new methods for vaccinating humans against human immunodeficiency virus (HIV), the virus that causes AIDS.

25 May 2004

Bacteria found in the mouth can block the HIV virus

Certain strains of bacteria that occur naturally in the human mouth can snare the HIV virus and even cells it has infected, according to researchers at the University of Illinois at Chicago College of Dentistry. They report their findings today at the 104th General Meeting of the American Society for Microbiology.

25 May 2004

Causes of hepatitis and potential therapies that may improve care presented in study

Hepatitis, a potentially serious disease caused by a virus that attacks the liver, is a major problem worldwide. Hepatitis A is generally food-borne, while hepatitis B and C spread primarily through parenteral or sexual routes. Hepatitis B and C can be life-long, potentially deadly chronic infections.

19 May 2004

AIDS nursing homes to get better Medicare deal

Nursing homes treating patients with Acquired Immune Deficiency Syndrome—AIDS—will see an increase in their Medicare payment rates this fall, according to Mark B. McClellan, M.D., Ph.D., administrator of the Centers for Medicare & Medicaid Services, the agency that oversees the program.

6 May 2004

World's first gene therapy trial aimed at preventing cancer

The concept seems straightforward. If, at its heart, cancer is a disease of genes, then giving patients new genes should disarm cancer. Such treatment would replace missing or faulty genes that keep cell growth in check, or would flush the body with "super genes" that could attack and destroy cancer.

5 May 2004

Immunodeficiency News and Research

Further Reading

Discovery of new ways to manipulate AIDS virus

Dynamics between disposable and reusable segments affect expansion of disposable drapes and gowns markets

Approval of an injectable filler to correct facial fat loss in people with HIV/AIDS

Risk of pelvic inflammatory disease (PID) decreases with condom use

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

Yoweri Kaguta Museveni has caused a major divide among participants of the AIDS Conference in Thailand

Widespread prenatal HIV screening and use of antiretroviral drugs in pregnant HIV-infected women is needed

Comparison of antiretroviral therapies shows that tenofovir DF and stavudine are equally effective

Nevirapine effective in reducing the risk of transmission of HIV at birth

Launch of the Jeffrey Modell Diagnostic Center for Primary Immunodeficiencies

Ugandans highly knowledgeable about HIV vaccine and willing to participate in future trials

Australian researchers awarded funding for new HIV vaccines

WHO welcomes G8 endorsement of the Global HIV Vaccine Enterprise

Double-punch approach to vaccine design more effective

Research into flipping genes therapy by Leeds University

$3.5 million grant to develop AIDS vaccinations

Bacteria found in the mouth can block the HIV virus

Causes of hepatitis and potential therapies that may improve care presented in study

AIDS nursing homes to get better Medicare deal

World's first gene therapy trial aimed at preventing cancer

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News